PRKN and cancer: Moreover, inhibition of DRP1 prevents PINK1 accumulation and Parkin recruitment, accompanied by alleviation of mitochondrial dysfunction and anti-cancer efficiency in response to flubendazole treatment, suggesting that DRP1-mediated excessive mitophagy may lead to cell death.